1. Home
  2. PDYN vs ACIU Comparison

PDYN vs ACIU Comparison

Compare PDYN & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palladyne AI Corp.

PDYN

Palladyne AI Corp.

HOLD

Current Price

$5.78

Market Cap

281.7M

Sector

Industrials

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$2.78

Market Cap

247.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDYN
ACIU
Founded
1983
2003
Country
United States
Switzerland
Employees
70
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
281.7M
247.6M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
PDYN
ACIU
Price
$5.78
$2.78
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$9.67
$10.00
AVG Volume (30 Days)
772.2K
236.8K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
108.86
N/A
EPS
N/A
N/A
Revenue
$5,246,000.00
N/A
Revenue This Year
$384.48
$706.75
Revenue Next Year
$63.16
$321.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.14
$2.10
52 Week High
$10.73
$4.00

Technical Indicators

Market Signals
Indicator
PDYN
ACIU
Relative Strength Index (RSI) 48.51 56.97
Support Level $4.72 $2.57
Resistance Level $6.35 $3.00
Average True Range (ATR) 0.26 0.16
MACD -0.05 0.00
Stochastic Oscillator 44.44 62.83

Price Performance

Historical Comparison
PDYN
ACIU

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: